Skip to main content

US FDA approves Krintafel (tafenoquine) for the radical cure of P. vivax malaria

Photo: Vivian Zanatta
Doing research on malaria or NTDs? Request the Pathogen Box, free of charge.

Photo: BMC St Jude
Read up-to-date articles highlighting our activities and the financial statement for 2017

Photo: Toby Madden/Transaid

Achievements

.

>90%

of severe malaria cases

now treated with injectable artesunate in preference to quinine across 6 countries through the MMV-led ISMO project
.

68m

courses of SMC

delivered to countries in the Sahel in 2017, enough to protect 17 million children
.

18,000

health-care workers

across 2,082 health-care facilities trained to administer injectable artesunate for severe malaria

Home

News

MMV committed to working with partners to increase access to new malaria medicines in high-burden countries today and developing simpler, more effective next-generation medicines to accelerate progress tomorrow

World Malaria Report highlights importance of country-led efforts to defeat malaria in highest burden countries

Defeating malaria together

Featured resources

Events